Prospective Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Jul 21, 2021; 27(27): 4468-4480
Published online Jul 21, 2021. doi: 10.3748/wjg.v27.i27.4468
Table 3 Hierarchical linear regression for patient’s inflammatory bowel disease-knowledge inventory device score as an independent variables (model 3; details of model 1 and 2 are shown in Supplementary Table 2)
Independent variablesModel 3


B (SE)
Beta
P value
Patient’s sex-1.03 (0.44)-0.130.021
Place of residence0.41 (0.45)0.050.37
Patient’s age0.03 (0.01)0.24< 0.001
Patient’s self-assessment of knowledgeLow vs medium-1.87 (1.46)-0.120.20
Good vs medium-0.74 (0.74)-0.090.32
Parent’s self-assessment of knowledgeLow vs medium-1.24 (1.68)-0.080.46
Good vs medium-1.66 (0.74)-0.210.026
J-elita membership0.69 (0.55)0.070.21
Internet as a source of knowledge0.67 (0.47)0.080.16
Parent’s IBD-KID score0.33 (0.06)0.32< 0.001
Immunosuppressive agent-0.12 (0.51)-0.010.82
Biological agent0.26 (0.52)0.030.61
Nutritional therapy0.38 (0.48)0.050.43
Surgical therapy1.26 (0.76)0.100.098
Raw/Corrected R20.311/0.269
F for change in R21.108
P value for R2 change0.35